BITWISE MARA INCOME STRAT (IMRA) Stock Price, Forecast & Analysis

NYSEARCA:IMRA • US0917487078

13.7686 USD
+0.99 (+7.76%)
Last: Feb 13, 2026, 08:17 PM
Overview Stock Chart Technical Analysis News

IMRA Key Statistics, Chart & Performance

Key Statistics
Market Cap361.20M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares26.23M
Float16.64M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)03-13
IPO2020-03-12
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
IMRA short term performance overview.The bars show the price performance of IMRA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

IMRA long term performance overview.The bars show the price performance of IMRA in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of IMRA is 13.7686 USD. In the past month the price decreased by -18.57%.

BITWISE MARA INCOME STRAT / IMRA Daily stock chart

IMRA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
IMRA Full Technical Analysis Report

IMRA Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO30.99981.56B
JNJ JOHNSON & JOHNSON20.9589.194B
MRK MERCK & CO. INC.22.44295.956B
PFE PFIZER INC9.18156.186B
BMY BRISTOL-MYERS SQUIBB CO9.98121.86B
ZTS ZOETIS INC18.4455.368B
RPRX ROYALTY PHARMA PLC- CL A8.7125.86B
VTRS VIATRIS INC6.2318.186B
ELAN ELANCO ANIMAL HEALTH INC24.0412.317B
AXSM AXSOME THERAPEUTICS INC221.279.222B

Related stock screener links

View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find more ETFs on the USA exchanges | Find stocks with similar TA and Setup ratings on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges

BITWISE MARA INCOME STRAT / IMRA FAQ

What does IMRA do?

Imara, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Brookline, Massachusetts and currently employs 6 full-time employees. The company went IPO on 2020-03-12. The firm is focused on developing and commercializing therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin and other serious diseases. Its lead product candidate, tovinontrine (IMR-687), is an oral, highly selective, potent small molecule inhibitor of phosphodiesterase-9 (PDE9). PDE9 selectively degrades cyclic guanosine monophosphate (cGMP), an active signaling molecule. IMR-687 is in Phase IIb clinical development for the treatment of sickle cell disease (SCD) and beta- thalassemia. The company is also focused on initiating a Phase II clinical trial of IMR-687 in heart failure with preserved ejection fraction (HFpEF). The firm is also focused on development of IMR-261, an oral, clinic-ready activator of nuclear factor erythroid 2-related factor 2 (Nrf2).


What is the current price of IMRA stock?

The current stock price of IMRA is 13.7686 USD. The price increased by 7.76% in the last trading session.


How is the ChartMill rating for BITWISE MARA INCOME STRAT?

IMRA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.